Plague as a Bioweapon

Introduction & Agent - The Black Death 2.0

• Causative Agent: Yersinia pestis
  • Gram-negative, non-motile coccobacillus.
  • Characteristic bipolar "safety-pin" appearance with Wayson or Giemsa stain.
  • Facultative anaerobe, facultative intracellular pathogen.
• Historical Impact: Responsible for devastating pandemics, notably the "Black Death" (14th century).
• Bioterrorism Classification:
  • CDC Category A agent: high priority.
  • Reasons: Ease of aerosol dissemination, high mortality rates (especially pneumonic plague), public panic potential.

⭐ Yersinia pestis virulence factors include the F1 capsular antigen (antiphagocytic) and V/W antigens (disrupt host cell signaling).

Clinical Forms & Transmission - Lungs Under Siege

• Three Main Forms:
  • Bubonic Plague: Most common natural form. Via flea bite. Results in painful, swollen lymph nodes (buboes). Low person-to-person transmission.
  • Septicemic Plague: Yersinia pestis invades bloodstream. Can be primary or secondary. High mortality; may cause Disseminated Intravascular Coagulation (DIC).
  • Pneumonic Plague: Lung infection. Primary concern for bioterrorism.
    • Transmission: Inhalation of aerosolized bacteria (bioterrorism) or respiratory droplets from infected individuals.
    • Incubation Period: 1-4 days.
    • Symptoms: Acute fever, chills, cough with bloody sputum, dyspnea. Progresses rapidly.
    • Highly contagious; high mortality if untreated.

⭐ Pneumonic plague is the most dangerous form in a bioterrorism scenario due to its direct person-to-person aerosol transmission and rapid progression.

Bioterrorism & Diagnosis - Spotting the Attack

• Bioweapon Form: Aerosolized Y. pestis → primary pneumonic plague.

  • Incubation: 1-6 days (aerosol: 1-3 days). Rapid progression.

• Attack Indicators:

  • Sudden cluster of severe febrile respiratory illness.
  • Atypical demographics/season.
  • No common travel/source.

• Key Symptoms (Pneumonic):

  • Fever, cough, dyspnea, hemoptysis.
  • Sepsis, respiratory failure in 2-4 days.

• Diagnosis:

  • High suspicion in mass casualty event.
  • CXR: bilateral infiltrates.
  • Labs: Gram-negative coccobacilli (bipolar "safety pin" stain), culture (Y. pestis), PCR, F1 antigen.

  ⭐ Pneumonic plague is the most likely form in bioterrorism (aerosol) and is highly transmissible person-to-person.

Management & Prevention - Fighting Back Fast

• Treatment: Start antibiotics within 24h (pneumonic).
  • Primary: Streptomycin (1g IM BD) or Gentamicin (5mg/kg/day).
  • Alternatives: Doxycycline (100mg PO BD), Ciprofloxacin (500mg PO BD), Levofloxacin.
• Post-Exposure Prophylaxis (PEP):
  • For close contacts (<2m pneumonic patient) or lab exposure.
  • Duration: 7 days. Drugs: Doxycycline, Ciprofloxacin, Levofloxacin.

  ⭐ PEP for 7 days with Doxycycline or Ciprofloxacin is crucial for contacts of pneumonic plague.

• Infection Control & Prevention:
  • Pneumonic: Strict respiratory (droplet) isolation for ≥48-72h post-antibiotics.
  • Standard precautions for bubonic.
  • Disinfection, vector (flea) & rodent control.

High‑Yield Points - ⚡ Biggest Takeaways

• Agent: Yersinia pestis, a Gram-negative coccobacillus with bipolar staining ("safety pin").
• Bioterrorism Threat: Aerosolized bacteria causing pneumonic plague is the primary concern.
• Pneumonic Plague: Presents with acute fever, bloody sputum (hemoptysis), dyspnea, and rapid shock.
• Key Diagnostic Feature: "Safety pin" appearance of Y. pestis on Wayson or Giemsa stain.
• Treatment of Choice: Aminoglycosides (Streptomycin, Gentamicin); alternatives include doxycycline, ciprofloxacin.
• Critical Timing: Treatment for pneumonic plague must start within 24 hours of symptom onset.
• Classification: A Category A bioterrorism agent due to high infectivity and mortality.